Graphite Bio
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Graphite Bio and buy or sell other stocks, ETFs, and their options commission-free!About GRPH
LENZ Therapeutics, Inc. is a pre-commercial biopharmaceutical company, which focuses on the development and commercialization of innovative therapies to improve vision. It offers eye drop product treatment for presbyopia.
CEOEvert B. Schimmelpennink
CEOEvert B. Schimmelpennink
Employees42
Employees42
HeadquartersSolana Beach, California
HeadquartersSolana Beach, California
Founded
Founded
Employees42
Employees42
GRPH Key Statistics
Market cap457.41M
Market cap457.41M
Price-Earnings ratio-7.59
Price-Earnings ratio-7.59
Dividend yield—
Dividend yield—
Average volume638.73K
Average volume638.73K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$50.40
52 Week high$50.40
52 Week low$15.36
52 Week low$15.36
Stock Snapshot
With a market cap of 457.41M, Graphite Bio(GRPH) trades at $16.00. The stock has a price-to-earnings ratio of -7.59.
During the trading day, Graphite Bio(GRPH) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Graphite Bio(GRPH) stock has reached 0, versus its average volume of 638.73K.
Over the past 52 weeks, Graphite Bio(GRPH) stock has traded between a high of $50.40 and a low of $15.36.
Over the past 52 weeks, Graphite Bio(GRPH) stock has traded between a high of $50.40 and a low of $15.36.
People also own
Based on the portfolios of people who own GRPH. This list is generated using Robinhood data, and it’s not a recommendation.